Differences in antigen recognition and cytolytic activity of CD8+ and CD8 T cells that express the same antigen-specific receptor

  1. Bryan K. Cho*,
  2. Kuo-Chiang Lian*,
  3. Peter Lee,
  4. Anders Brunmark,
  5. Carol McKinley*,
  6. Jianzhu Chen*,
  7. David M. Kranz, and
  8. Herman N. Eisen*,§
  1. *Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; R. W. Johnson Pharmaceutical Research Institute, San Diego, CA 92121; and Department of Biochemistry, University of Illinois, Urbana, IL 61801
  1. Contributed by Herman N. Eisen

Abstract

CD8+ and CD8 T cell lines expressing the same antigen-specific receptor [the 2C T cell receptor (TCR)] were compared for ability to bind soluble peptide-MHC and to lyse target cells. The 2C TCR on CD8 cells bound a syngeneic MHC (Kb+)-peptide complex 10–100 times less well than the same TCR on CD8+ cells, and the CD8 2C cells lysed target cells presenting this complex very poorly. Surprisingly, however, the CD8 cells differed little from CD8+ cells in ability to bind an allogeneic MHC (Ld+)-peptide complex and to lyse target cells presenting this complex. The CD8+/CD8 difference provided an opportunity to estimate how long TCR engagements with peptide-MHC have to persist to initiate the cytolytic T cell response.

Footnotes

  • § To whom reprint requests should be addressed. E-mail: hneisen{at}mit.edu.

  • Abbreviations:
    TCR,
    T cell receptor;
    pepMHC,
    peptide-MHC;
    APC,
    antigen-presenting cell;
    CTL,
    cytotoxic T lymphocyte
« Previous | Next Article »Table of Contents